Lactobacillus rhamnosus protects human colonic muscle from pathogen lipopolysaccharide-induced damage

Neurogastroenterology and Motility

Volumn 25, Issue 12, 2013, Pages

  Ammoscato, F ^a   Scirocco, A ^a   Altomare, A ^b   Matarrese, P ^c   Petitta, C ^a   Ascione, B ^c   Caronna, R ^a   Guarino, M ^b   Marignani, M ^d   Cicala, M ^b   Chirletti, P ^a   Malorni, W ^c   Severi, C ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antipathogenic compounds; Human colonic smooth muscle; Lactobacillus rhamnosus GG; Myogenic dysfunction; Reversion of LPS damage; Toll like receptors

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2;

ARTICLE; BACTERIAL STRAIN; COLON; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; ESCHERICHIA COLI; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LACTOBACILLUS RHAMNOSUS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SMOOTH MUSCLE; SUPERNATANT;

ANTIPATHOGENIC COMPOUNDS; HUMAN COLONIC SMOOTH MUSCLE; LACTOBACILLUS RHAMNOSUS GG; MYOGENIC DYSFUNCTION; REVERSION OF LPS DAMAGE; TOLL-LIKE RECEPTORS;

CELLS, CULTURED; COLON; GASTROINTESTINAL MOTILITY; HUMANS; LACTOBACILLUS RHAMNOSUS; LIPOPOLYSACCHARIDES; MUSCLE, SMOOTH; PROBIOTICS;

EID: 84888059036     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12232     Document Type: Article

References (44)

1. Verdu EF, Berci P, Bergonzelli GE. Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction. Gastroenterology 2004; 127: 826-37.
2. Bär F, Von Koschitzky H, Roblick U et al. Cell-free supernatants of Escherichia coli Nissle 1917 [EcN] modulate human colonic motility: evidence from an in vitro organ bath study. J Neurogastroenterol Motil 2009; 21: 559-66.
3. Massi M, Ioan P, Budriesi R et al. Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue. World J Gastroenterol 2006; 12: 5987-94.
4. Wang B, Mao YK, Diorio C et al. Luminal administration ex vivo of a live Lactobacillus species moderates mouse jejunal motility within minutes. Faseb J 2010; 24: 4078-88.
5. Guarino MPL, Altomare A, Stasi E et al. Effect of acute mucosal exposure to Lactobacillus rhamnosus GG on human colonic smooth muscle cells. J Clin Gastroenterol 2008; 42: 185-90.
6. Kunze WA, Mao YK, Wang B et al. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. J Cell Mol Med 2009; 13: 2261-70.
7. Quigley EM. Microflora modulation of motility. J Neurogastyroenterol Motil 2011; 17: 140-7.
8. Barbara G, Stanghellini V, Brandi G et al. Interactions between commensal bacteria and gut sensorimotor function in health. Am J Gastroenterol 2005; 100: 2560-8.
9. Husebye E, Hellström PM, Sundler F, Chen J, Midtvedt T. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 2001; 280: 368-80.
10. Brown J, Wang H, Hajishengallis GN, Martin M. TLR-signaling networks: An integration of adaptor molecules, kinases, an cross-talk. J Dent Res 2011; 90: 417-27.
11. Tattoli I, Petitta C, Scirocco A et al. Microbiota, innate immune system and gastrointestinal muscle: on going-studies. J Clin Gastroenterol 2012; 46: S6-11.
12. Boyd JH, Mathur S, Wang Y, Bateman RM, Walley KR. Toll-like receptor stimulation in cardiomyocytes decreases contractility and initiates an NF-kappaB dependent inflammatory response. Cardiovasc Res 2006; 72: 384-93.
13. Ha T, Hu Y, Liu L et al. TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism. Am J Physiol Heart Circ Physiol 2010; 298: H984-91.
14. Iyer LM, Aravind L, Coon SL, Klein DC, Koonin EV. Evolution of cell-cell signaling in animals: did late horizontal gene transfer from bacteria have a role? Trends Genet 2004; 20: 292-9.
15. Di Giancamillo A, Vitari F, Bosi G, Savoini G, Domeneghini C. The chemical code of porcine enteric neurons and the number of enteric glial cells are altered by dietary probiotics. Neurogastroenterol Motil 2010; 22: e271-8.
16. Forsythe P, Kunze WA. Voices from within: gut microbes and the CNS. Cell Mol Life Sci 2013; 70: 55-69.
17. Petrof EO, Kojima K, Ropeleski MJ et al. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 2004; 127: 1474-87.
18. Petrof EO, Claud EC, Sun J et al. Bacteria-free solution derived from Lactobacillus plantarum inhibits multiple NF-kappaB pathways and inhibits proteasome function. Inflamm Bowel Dis 2009; 15: 1537-47.
19. Petrof EO. Probiotics and gastrointestinal diseases: clinical evidence and basic science. Antinflamm Antiallergy Agents Med Chem 2009; 8: 260-9.
20. Riedel CU, Foata F, Philippe D, Adolfsson O, Eikmanns BJ, Blum S. Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation. World J Gastroenterol 2006; 12: 3729-35.
21. Sun J, Hu XL, Le GW, Shi YH. Lactobacilli prevent hydroxyl radical production and inhibit Escherichia coli and Enterococcus growth in system mimicking colon fermentation. Lett Appl Microbiol 2010; 50: 264-9.
22. Liu Y, Fatheree NY, Mangalat N, Rhoads JM. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2010; 299: 1087-96.
23. Arribas B, Rodríguez-Cabezas ME, Comalada M et al. Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice. Br J Nutr 2009; 101: 51-8.
24. Howarth GS, Wang H. Role of endogenous microbiota, probiotics and their biological products in human health. Nutrients 2013; 5: 58-81.
25. Scirocco A, Matarrese P, Petitta C et al. Exposure of toll-like receptors 4 to bacterial lipopolysaccharide [LPS] impairs human colonic smooth muscle cell function. J Cell Physiology 2010; 223: 442-50.
26. Matarrese P, Petitta C, Scirocco A et al. Antioxidants counteract lipopolysaccharide-triggered alterations 1 of human colonic smooth muscle cells. Free Radic Biol Med 2012; 53: 2102-11.
27. Verdu EF. Probiotics effects on gastrointestinal function: beyond the gut? Neurogastroenterol Motil 2009; 21: 477-80.
28. Biancani P, Zabinski M, Kerstein M, Behar J. Lower esophageal sphincter mechanics: anatomic and physiologic relationships of the esophagogastric junction of the cat. Gastroenterology 1982; 82: 468-75.
29. Tattoli I, Corleto VD, Taffuri M et al. Optimisation of isolation of richly pure and homogeneous primary human colonic smooth muscle cells. Dig Liver Dis 2004; 36: 735-43.
30. Frick JS, Schenk K, Quitadamo M et al. Lactobacillus fermentum attenuates the proinflammatory effect of Yersinia enterocolitica on human epithelial cells. Inflamm Bowel Dis 2007; 13: 83-90.
31. Maselli MA, Trisolini P, Petitta C et al. Myogenic regional responsiveness to cholinergic and vipergic stimulation in human colon. Neurogastroenterol Motil 2012; 24: 867-e399.
32. Abdi J, Mutis T, Garssen J et al. Characterization of the Toll-like receptor expression profile in human multiple myeloma cells. PLoS ONE 2013; 8: e60671.
33. Hu W, Li F, Mahavadi S, Murthy KS. Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway. Am J Physiol Cell Physiol 2009; 296: 1310-20.
34. Arbibe L, Mira JP, Teusch N et al. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol 2000; 1: 533-40.
35. Fukao T, Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol 2003; 24: 358-63.
36. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
37. O'Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128: 541-51.
38. Ciorba MA, Riehl TE, Suprada Rao M et al. Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner. Gut 2012; 61: 829-38.
39. Shkoda A, Ruiz PA, Daniel H et al. Interleukin-10 blocked endoplasmatic reticulum stress in intestinal epithelial cells: impact on chronic inflammation. Gastroenterology 2007; 132: 190-207.
40. Re F, Strominger JL. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol 2004; 173: 7548-55.
41. Bermudes-Brito M, Munoz-Quezada S, Gomez-Llorente C et al. Human intestinal dendritic cells decrease cytokine release against Salmonella infection in the presence of Lactobacillus paracasei upon TLR activation. PlosOne 2012; 7: e43197.
42. Wang Y, Liu Y, Kirpich I et al. Lactobacillus rhamnosus GG reduces hepatic TNFα production and inflammation in chronic alcohol-induced liver injury. J Nutr Biochem 2013; 24: 1609-15.
43. Tsilingiri K, Barbosa T, Penna G et al. Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Gut 2012; 61: 1007-15.
44. Bermudes-Brito M, Munoz-Quezada S, Gomez-Llorente C et al. Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation. PlosOne 2013; 8: e59370.